Comparison of quality of life between 2-year and 3-or-more-year administration of leuprorelin acetate every-3-months depot in combination with tamoxifen as adjuvant endocrine treatment in premenopausal patients with endocrine-responsive breast cancer: a randomized controlled trial

Yasuo Ohashi, Eiichi Shiba, Hiroko Yamashita, Junichi Kurebayashi, Shinzaburo Noguchi, Hirotaka Iwase, Michihiro Yoshida, Tsukasa Fujimoto

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Comparison of quality of life between 2-year and 3-or-more-year administration of leuprorelin acetate every-3-months depot in combination with tamoxifen as adjuvant endocrine treatment in premenopausal patients with endocrine-responsive breast cancer: a randomized controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences